146 related articles for article (PubMed ID: 6149326)
1. [A case of refractory chronic Zollinger-Ellison syndrome--treated successfully with famotidine].
Shiratori K; Watanabe S; Maruyama M; Adachi H; Itoh Y; Kurokawa K; Takeuchi T
Nihon Shokakibyo Gakkai Zasshi; 1984 Jul; 81(7):1623-7. PubMed ID: 6149326
[No Abstract] [Full Text] [Related]
2. Famotidine: effective treatment of Zollinger-Ellison syndrome.
Howard JM; Vinayek R; Maton PN; Wank SA; Gardner JD; Jensen RT
J Clin Gastroenterol; 1987; 9 Suppl 2():23-5. PubMed ID: 2887615
[TBL] [Abstract][Full Text] [Related]
3. Famotidine, a new, potent, long-acting histamine H2-receptor antagonist: comparison with cimetidine and ranitidine in the treatment of Zollinger-Ellison syndrome.
Howard JM; Chremos AN; Collen MJ; McArthur KE; Cherner JA; Maton PN; Ciarleglio CA; Cornelius MJ; Gardner JD; Jensen RT
Gastroenterology; 1985 Apr; 88(4):1026-33. PubMed ID: 2857672
[TBL] [Abstract][Full Text] [Related]
4. Famotidine. Pharmacodynamic and pharmacokinetic properties and a preliminary review of its therapeutic use in peptic ulcer disease and Zollinger-Ellison syndrome.
Campoli-Richards DM; Clissold SP
Drugs; 1986 Sep; 32(3):197-221. PubMed ID: 2875864
[TBL] [Abstract][Full Text] [Related]
5. [24-hour intragastric acid profile in a ZES patient with H2 blockers].
Dammann HG; Müller P; Simon B; Kommerell B
Z Gastroenterol; 1984 Jun; 22(6):318-20. PubMed ID: 6147052
[No Abstract] [Full Text] [Related]
6. Recent advances in the management of gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
Maton PN; Gardner JD; Jensen RT
Gastroenterol Clin North Am; 1989 Dec; 18(4):847-63. PubMed ID: 2575602
[TBL] [Abstract][Full Text] [Related]
7. Famotidine. The ACG Committee on FDA-Related Matters with primary authorship by G. Friedman. American College of Gastroenterology.
Am J Gastroenterol; 1987 Jun; 82(6):504-6. PubMed ID: 2883885
[TBL] [Abstract][Full Text] [Related]
8. Famotidine in the therapy of gastric hypersecretory states.
Vinayek R; Howard JM; Maton PN; Wank SA; Slaff JI; Gardner JD; Jensen RT
Am J Med; 1986 Oct; 81(4B):49-59. PubMed ID: 2877575
[TBL] [Abstract][Full Text] [Related]
9. Omeprazole in the treatment of Zollinger-Ellison syndrome and histamine H2-antagonist refractory ulcers.
Meijer JL; Jansen JB; Lamers CB
Digestion; 1989; 44 Suppl 1():31-9. PubMed ID: 2575060
[TBL] [Abstract][Full Text] [Related]
10. Parenteral control of gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
Vinayek R; Hahne WF; Euler AR; Norton JA; Jensen RT
Dig Dis Sci; 1993 Oct; 38(10):1857-65. PubMed ID: 8104773
[TBL] [Abstract][Full Text] [Related]
11. [The role of H2 antagonists in Zollinger-Ellison syndrome].
Dammann HG; Walter TA; Müller P; Simon B
Clin Ter; 1984 Dec; 111(5):393-400. PubMed ID: 6151434
[No Abstract] [Full Text] [Related]
12. Treatment with H2 receptor antagonists. Zollinger-Ellison Syndrome.
Siepler JK; Donahue P; Campagna K; Bombeck CT
IMJ Ill Med J; 1978 Apr; 153(4):283-7. PubMed ID: 25249
[No Abstract] [Full Text] [Related]
13. H2 receptor antagonists.
Siepler JK; Campagna KD; Donahue PE; Bombeck CT
Am J Hosp Pharm; 1978 Feb; 35(2):141-5. PubMed ID: 24338
[TBL] [Abstract][Full Text] [Related]
14. Use of ranitidine in the medical treatment of Zollinger-Ellison syndrome.
Bonfils S; Mignon M; Vallot ; Mayeur S
Scand J Gastroenterol Suppl; 1981 Jun; 69():119-23. PubMed ID: 6119775
[No Abstract] [Full Text] [Related]
15. Management of patients with the Zollinger-Ellison syndrome.
Mocek FW; Richardson R; Williams R; Richardson JD
J Ky Med Assoc; 1993 Sep; 91(9):403-7. PubMed ID: 7901311
[TBL] [Abstract][Full Text] [Related]
16. Uncertainties in the management of the Zollinger-Ellison Syndrome.
Malagelada JR
Gastroenterology; 1983 Jan; 84(1):188-9. PubMed ID: 6128287
[No Abstract] [Full Text] [Related]
17. [Histamine H-2 receptor antagonists and medical treatment of Zollinger-Ellison syndrome].
Bonfils S; Mignon M; Kloeti G
Sem Hop; 1978 Mar; 54(5-8):309-12. PubMed ID: 29338
[TBL] [Abstract][Full Text] [Related]
18. [Management of the hypersecretion of acid in Zollinger-Ellison syndrome (ZES)].
Varas MJ; López A; Gordillo J
Rev Esp Enferm Apar Dig; 1989 Apr; 75(4):419-20. PubMed ID: 2568007
[No Abstract] [Full Text] [Related]
19. [Treatment of Zollinger-Ellison syndrome. Strategy and oncologic approach].
Bonfils S
Gastroenterol Clin Biol; 1983; 7(8-9):653-6. PubMed ID: 6137433
[No Abstract] [Full Text] [Related]
20. The medical management of Zollinger-Ellison syndrome.
Rhodes JM
Q J Med; 1991 Mar; 78(287):191-3. PubMed ID: 1675470
[No Abstract] [Full Text] [Related]
[Next] [New Search]
